ClinVar Miner

Submissions for variant NM_000022.4(ADA):c.704G>A (p.Arg235Gln) (rs79281338)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000215113 SCV000271204 likely pathogenic Severe combined immunodeficiency due to ADA deficiency 2015-11-09 criteria provided, single submitter clinical testing The p.Arg235Gln variant in ADA has been reported in 3 individuals with SCID due to adenosine deaminase deficiency, confirmed by decreased ADA enzyme activity in patient cells (Ariga 2001a, Baffelli 2015). All of these individuals were compo und heterozygous and two of them had a second ADA variant predicted to cause los s of function of the gene on the other allele. The p.Arg235Gln variant was absen t from large population studies. Computational prediction tools and conservation analyses suggest that the variant may impact the protein, though this informati on is not predictive enough to determine pathogenicity. Furthermore, in vitro fu nctional studies provide some evidence that this variant impacts protein functio n (Ariga 2001b), although these types of assays may not accurately represent bio logical function. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic.
Counsyl RCV000215113 SCV000794032 likely pathogenic Severe combined immunodeficiency due to ADA deficiency 2017-09-06 criteria provided, single submitter clinical testing
Invitae RCV000215113 SCV000813414 pathogenic Severe combined immunodeficiency due to ADA deficiency 2020-05-04 criteria provided, single submitter clinical testing This sequence change replaces arginine with glutamine at codon 235 of the ADA protein (p.Arg235Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in combination with other ADA variants in several individuals affected with adenosine deaminase deficiency (PMID: 11313286, 26376800). In two individuals with ADA enzyme deficiency, this variant was observed on the opposite chromosome (in trans) from another pathogenic ADA variant (PMID: 11313286). This finding is consistent with autosomal recessive inheritance, and suggests that this variant contributes to disease. ClinVar contains an entry for this variant (Variation ID: 228244). Experimental studies have shown that this missense change impairs ADA enzyme activity in vitro (PMID: 11160213). The p.Arg235Trp amino acid residue in ADA has been determined to be clinically significant (PMID: 21624848, 26255240, 26376800, Invitae). This suggests that variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.